- Tytuł:
- A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
- Autorzy:
- Źródło:
- In The Lancet Regional Health - Western Pacific July 2022 24
Czasopismo naukowe